Merck Announces KEYNOTE-598 Trial Evaluating KEYTRUDA® in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic Non-Small Cell Lung Cancer To Stop for Futility and Patients to Discontinue... Pharmaceutical Investing
Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020 Biotech Investing
Amgen Showcases New Data Across Cardiovascular Portfolio At AHA Scientific Sessions 2020: A Virtual Experience Biotech Investing
Seelos Therapeutics to Participate in the 3rd International Conference on Sanfilippo Syndrome and Related Diseases Psychedelics Investing
Algernon Pharmaceuticals Announces Plans to Provide Interim Data from its Ifenprodil Phase 2b/3 COVID-19 Human Study Biotech Investing
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care Psychedelics Investing
Bristol Myers Squibb Presents Late-Breaking Phase 2 Data Demonstrating the Safety and Efficacy of Deucravacitinib in Patients with Psoriatic Arthritis Biotech Investing
 Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study Pharmaceutical Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
